Concepedia

Waheed Khan

WK

4

Publications

62

Citations

4

H-Index

2014

Active since

Affiliations

Boston Biomedical (United States)(Current)

Texas Oncology

Waheed Khan is an author at Boston Biomedical (United States) specializing in oncology, cancer therapeutics, and cancer research.

Top concepts

Publications per year

2014–2018

4

Publications

4

Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics of Efavirenz 400 mg Once Daily During Pregnancy and Post-Partum

Mohammed Lamorde, Xinzhu Wang, Megan Neary et al. · Clinical Infectious Diseases · 2018 · 26 citations · Full text

Real-life effectiveness, safety, and tolerability of amlodipine/valsartan or amlodipine/valsartan/hydrochlorothiazide single-pill combination in patients with hypertension from Pakistan

Waheed Khan, Nasir Moin, Somia Iktidar et al. · Therapeutic Advances in Cardiovascular Disease · 2014 · 15 citations · Full text

BBI608-503-103HCC: A phase Ib/II clinical study of napabucasin (BBI608) in combination with sorafenib or amcasertib (BBI503) in combination with sorafenib (Sor) in adult patients with hepatocellular carcinoma (HCC).

Bassel F. El‐Rayes, Donald Richards, Allen Lee Cohn et al. · Journal of Clinical Oncology · 2017 · 11 citations

, , +15

BBI608-224: A phase Ib/II study of cancer stemness inhibitor napabucasin (BBI-608) administered with panitumumab in KRAS wild-type patients with metastatic colorectal cancer.

Tim Larson, Waldo Feliu Ortuzar, Tanios Bekaii‐Saab et al. · Journal of Clinical Oncology · 2017 · 10 citations

, , +17

Rows per page

1–4 of 4